<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04861142</url>
  </required_header>
  <id_info>
    <org_study_id>3224</org_study_id>
    <nct_id>NCT04861142</nct_id>
  </id_info>
  <brief_title>Osteoporosis Treatment Protocol in Patients With Fragility Fractures: Application and Efficacy</brief_title>
  <official_title>Osteoporosis Treatment Protocol in Patients With Fragility Fractures: Application and Efficacy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University General Hospital of Heraklion</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University General Hospital of Heraklion</source>
  <brief_summary>
    <textblock>
      Osteoporosis and osteoporotic fractures, especially hip fractures, have a significant impact&#xD;
      on public healthcare. Despite the fact that the patients that have suffered an osteoporotic&#xD;
      fracture have 86% increased risk of sustaining a second osteoporotic fracture, the efforts to&#xD;
      prevent these fractures remain inadequate. The in-hospital initiation of antiosteoporotic&#xD;
      treatment in patients that have been admitted due to hip fracture has shown to improve&#xD;
      treatment rates and contribute to second fracture prevention. For this purpose the&#xD;
      Arbeitsgemeinschaft f√ºr Osteosynthesefragen (AO) Foundation has introduced an algorithm that&#xD;
      can be used by Orthopedic surgeons for the prevention of second fracture in patients that&#xD;
      have already suffered an osteoporotic fracture. The purpose of this thesis is to study the&#xD;
      efficacy of this algorithm in preventing the second fracture in the greek population. The&#xD;
      study will include patients that have been admitted in the Orthopedics department of the&#xD;
      University Hospital of Heraklion due to hip fracture. Bone density measurement will be&#xD;
      performed using the DXA method and antiosteoporotic treatment will be administered according&#xD;
      to the algorithm. These patients will be included in the hip registry of the Orthopedics&#xD;
      department and the follow-up will last for 2 years .The primary aims of the study are:&#xD;
      a)evaluation of the adherence to the antiosteoporotic medication b)the efficacy of the&#xD;
      adherence to the aforementioned clinical algorithm in the secondary fracture prevention in&#xD;
      the greek population.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 23, 2021</start_date>
  <completion_date type="Anticipated">October 2024</completion_date>
  <primary_completion_date type="Anticipated">May 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence to the prescribed anti-osteoporotic medication</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Secondary fracture incidence</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morbidity and mortality of operatively treated hip fractures in our department</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Osteoporosis</condition>
  <arm_group>
    <arm_group_label>Patients adherent to the anti-osteoporotic medication</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients non-adherent to the anti-osteoporotic medication</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Anti-osteoporotic medication( alendronate or denosumab)</intervention_name>
    <description>Initiation of anti-osteoporotic medication (alendronate or denosumab)</description>
    <arm_group_label>Patients adherent to the anti-osteoporotic medication</arm_group_label>
    <arm_group_label>Patients non-adherent to the anti-osteoporotic medication</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with hip fractures after low-energy falls (fragility fractures), that are&#xD;
        operatively treated in our department.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with hip fractures after low-energy falls(fragility fractures)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -Patients with hip fractures after high energy falls&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Ioannis Daskalakis, Orthopaedic Surgery Resident</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Heraklion</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Theodoros Tosounidis, Assistant Professor</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital of Heraklion</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Apostolos Karantanas, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital of Heraklion</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Georgios Kontakis, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital of Heraklion</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Theodoros Tosounidis, Assistant Professor</last_name>
    <phone>+30 2810395055</phone>
    <email>ttosounidis@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ioannis Daskalakis, Orthopaedic Surgery Resident</last_name>
    <phone>+30 6973324328</phone>
    <email>g_dask@hotmail.gr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of Heraklion</name>
      <address>
        <city>Heraklion</city>
        <state>Crete</state>
        <zip>71500</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Theodoros Tosounidis, Assistant Professor</last_name>
      <phone>+30 2810395055</phone>
      <email>ttosounidis@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Ioannis Daskalakis</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Theodoros Tosounidis</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Apostolos Karantanas</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Georgios Kontakis</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 22, 2021</study_first_submitted>
  <study_first_submitted_qc>April 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 27, 2021</study_first_posted>
  <last_update_submitted>April 22, 2021</last_update_submitted>
  <last_update_submitted_qc>April 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University General Hospital of Heraklion</investigator_affiliation>
    <investigator_full_name>Ioannis Daskalakis</investigator_full_name>
    <investigator_title>Orthopaedic surgery resident</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Denosumab</mesh_term>
    <mesh_term>Alendronate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

